🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/08/2022 | 87,81 | 89,82 | 87,36 | 88,93 | -0,29% | 2,80% | 7.396.800 |
| 10/08/2022 | 90,03 | 90,13 | 88,19 | 89,19 | -0,37% | 2,15% | 8.140.200 |
| 09/08/2022 | 88,75 | 90,24 | 86,81 | 89,52 | +1,16% | 3,86% | 13.215.500 |
| 08/08/2022 | 87,30 | 88,78 | 86,92 | 88,49 | +1,24% | 2,13% | 8.149.400 |
| 05/08/2022 | 86,53 | 87,53 | 86,02 | 87,41 | +0,68% | 1,75% | 8.801.200 |
| 04/08/2022 | 87,81 | 87,89 | 86,64 | 86,82 | -0,91% | 1,42% | 7.993.800 |
| 03/08/2022 | 87,25 | 88,02 | 86,76 | 87,62 | +0,01% | 1,44% | 8.187.600 |
| 02/08/2022 | 89,06 | 89,59 | 87,55 | 87,61 | -1,04% | 2,29% | 7.443.000 |
| 01/08/2022 | 89,34 | 90,02 | 88,35 | 88,53 | -0,91% | 1,87% | 7.343.300 |
| 29/07/2022 | 90,08 | 91,08 | 88,28 | 89,34 | -0,67% | 3,11% | 14.938.600 |
| 28/07/2022 | 91,04 | 91,13 | 87,42 | 89,94 | -1,41% | 4,08% | 13.909.800 |
| 27/07/2022 | 90,50 | 91,37 | 90,01 | 91,23 | -0,07% | 1,50% | 6.966.300 |
| 26/07/2022 | 91,40 | 91,95 | 90,60 | 91,29 | +0,84% | 1,48% | 6.414.100 |
| 25/07/2022 | 90,20 | 90,73 | 89,75 | 90,53 | +0,47% | 1,09% | 6.364.500 |
| 22/07/2022 | 90,11 | 90,45 | 89,46 | 90,11 | -0,03% | 1,10% | 6.354.500 |
| 21/07/2022 | 89,15 | 90,41 | 88,91 | 90,14 | +0,55% | 1,68% | 8.197.000 |
| 20/07/2022 | 92,36 | 92,43 | 89,22 | 89,65 | -2,93% | 3,48% | 11.844.000 |
| 19/07/2022 | 93,15 | 93,39 | 92,12 | 92,36 | +0,02% | 1,36% | 8.233.600 |
| 18/07/2022 | 94,90 | 95,10 | 91,92 | 92,34 | -2,76% | 3,35% | 8.653.700 |
| 15/07/2022 | 94,85 | 95,35 | 94,37 | 94,96 | +1,15% | 1,03% | 9.731.900 |
| 14/07/2022 | 92,55 | 94,06 | 92,06 | 93,88 | +0,12% | 2,16% | 6.271.000 |
| 13/07/2022 | 93,59 | 94,36 | 93,02 | 93,77 | +0,18% | 1,43% | 6.415.600 |
| 12/07/2022 | 93,78 | 94,24 | 93,14 | 93,60 | -0,74% | 1,17% | 7.826.500 |
| 11/07/2022 | 92,88 | 94,78 | 92,83 | 94,30 | +1,64% | 2,10% | 9.507.700 |
| 08/07/2022 | 92,91 | 93,82 | 92,41 | 92,78 | -0,25% | 1,52% | 7.161.500 |
| 07/07/2022 | 92,94 | 93,95 | 92,55 | 93,01 | -0,13% | 1,51% | 8.140.100 |
| 06/07/2022 | 93,31 | 94,51 | 92,70 | 93,13 | +0,53% | 1,94% | 10.455.300 |
| 05/07/2022 | 92,44 | 92,95 | 90,53 | 92,64 | +0,24% | 2,62% | 9.574.400 |
| 01/07/2022 | 91,30 | 92,49 | 90,39 | 92,42 | +1,37% | 2,30% | 11.413.800 |
| 30/06/2022 | 91,65 | 92,90 | 90,91 | 91,17 | -1,45% | 2,17% | 18.551.400 |